Azurrx biopharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Azurrx biopharma Contact Number

AzurRx BioPharma Crunchbase Company Profile & …

6 hours ago Crunchbase.com Show details

Company Type For Profit. Contact Email [email protected]azurrx.com. Phone Number (646)699-7855. AzurRx BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets.

Founded: 2014
Founder: Daniel Dupret

Category: Contact NumberShow more

Home First Wave BioPharma, Inc.

9 hours ago Firstwavebio.com Show details

(561) 589-7020

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma READ MORE CONTACT. 777 Yamato Road Suite 502 Boca Raton, FL 33431 (561) 589-7020: [email protected]: SOCIAL MEDIA. CONTACT. 777 Yamato Road Suite 502 Boca Raton, FL 33431 (561) 589-7020:

Category: Home PhoneShow more

FORM D SEC

4 hours ago Sec.gov Show details

(646) 699-7855

Principal Place of Business and Contact Information. Name of Issuer; AzurRx BioPharma, Inc. Street Address 1 Street Address 2; 1410 Broadway: 23rd Floor: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; New York: NEW YORK: 10018 (646) 699-7855: 3. Related Persons. Last Name First Name Middle Name; Spoor: Johan (Thijs) Street

Category: Contact NumberShow more

AzurRx BioPharma, Inc. The Richmond Club

6 hours ago Richmondclub.com Show details

(646) 713-2924

The stock is significantly undervalued — most of AzurRx’s peers are trading at three to four times their sales revenue. 2 Minute Company Overview For more information about AzurRx BioPharma, please contact Martin Krusin, SVP of Corporate Development at (646) 713-2924

Category: Contact NumberShow more

AzurRx BioPharma AzurRx BioPharma CEO Issues Clarifying

8 hours ago Azurrx.com Show details

(561) 589-7020

AzurRx BioPharma, Inc. 777 Yamato Road Suite 502 Boca Raton, FL 33431 . Tel: (561) 589-7020 [email protected]azurrx.com

Estimated Reading Time: 9 mins

Category: Contact NumberShow more

Tony Baca's email & phone AzurRx BioPharma's Vice

7 hours ago Rocketreach.co Show details

We had no where to begin. Scouring the web at all hours of the night wasn't gonna cut it. RocketReach has given us a great place to start. Our workflow has solid direction now - we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering.

Category: Phone NumberShow more

Azurrx Biopharma, Inc. in Brooklyn, NY Company Info

4 hours ago Bizapedia.com Show details

Azurrx Biopharma, Inc. is a New York Foreign Business Corporation filed On July 26, 2016. The company's filing status is listed as Active and its File Number is 4982866. The Registered Agent on file for this company is Daniel Schneiderman and is located at 1615 South Congress Ave Suite 103, Delray Beach, FL 33445.

Location: NY

Category: Contact NumberShow more

Home Covid GI

4 hours ago Covidgi.com Show details

About AzurRx BioPharma, Inc. AzurRx BioPharma, Inc. (NASDAQ: AZRX) (to be renamed “First Wave BioPharma, Inc.” with its common stock trading under new ticker symbol “FWBI” effective on or about September 23, 2021), is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.

Category: Home PhoneShow more

AzurRx BioPharma, Inc. (Form: 8K, Received EDGAR Online

7 hours ago Content.edgar-online.com Show details

On November 13, 2019 (the “Execution Date”), AzurRx BioPharma, Inc. (the “Company”) entered into a purchase agreement, dated as of the Execution Date (the “Purchase Agreement”), and a registration rights agreement, dated as of the Execution Date (the “Registration Rights Agreement”), with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park has

Category: Contact NumberShow more

AzurRx BioPharma CEO Issues Letter to Shareholders

Just Now Finance.yahoo.com Show details

AzurRx BioPharma, Inc. (NASDAQ: AZRX) (to be renamed “First Wave BioPharma, Inc.” with its common stock trading under new ticker symbol …

1. Author: Azurrx Biopharma, Inc.

Category: Contact NumberShow more

AzurRx BioPharma AzurRx BioPharma CEO Issues Letter to

8 hours ago Azurrx.com Show details

(561) 589-7020

AzurRx BioPharma, Inc. 777 Yamato Road Suite 502 Boca Raton, FL 33431 . Tel: (561) 589-7020 [email protected]azurrx.com

Category: Contact NumberShow more

Press Release: AzurRx BioPharma to Change Corporate Name

5 hours ago Sharecast.com Show details

AzurRx BioPharma to Change Corporate Name to Company's common shares will commence trading on the Nasdaq Capital Market under the new ticker symbol "FWBI" and CUSIP number (33749P101) at the

Category: Contact NumberShow more

AzurRx BioPharma, Inc. (Form: 8K, Received EDGAR Online

6 hours ago Content.edgar-online.com Show details

On December 31, 2020, AzurRx BioPharma, Inc. (the “Company”) entered into a License Agreement (the “License Agreement”) with First Wave Bio, Inc. (“First Wave”), a privately-held Delaware corporation. an increase in the number of authorized shares of Common Stock above 150,000,000 and (y) the potential issuance of shares of

Category: Contact NumberShow more

AzurRx BioPharma, Inc. Fintel

8 hours ago Fintel.io Show details

021-01-05

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 4, 2021 Commission File Number: 001-37853 AzurRx BioPharma, Inc. 2021-01-05.

Category: Contact NumberShow more

Azrx_ex991.htm

1 hours ago Sec.gov Show details

EXHIBIT 99.1 . AzurRx BioPharma Announces Reverse Stock-Split . Common Stock Will Begin Trading on Split-Adjusted Basis on September 13, 2021 . BOCA RATON, FL., September 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development in the development of targeted, …

Category: Contact NumberShow more

AzurRx BioPharma CEO Issues Letter to Shareholders

8 hours ago Apnews.com Show details

(561) 589-7020

For more information: AzurRx BioPharma, Inc. 777 Yamato Road, Suite 502 Boca Raton, FL 33431 Phone: (561) 589-7020 [email protected]azurrx.com. Media contact: Tiberend Strategic Advisors, Inc. Johanna Bennett / David Schemelia / Ingrid Mezo (212) 375-2665 / (609) 468-9325 / (646) 604-5150 [email protected] / [email protected] / [email protected]

1. Author: Azurrx Biopharma, Inc.

Category: Contact NumberShow more

Safety and Efficacy of Niclosamide in ClinicalTrials.gov

7 hours ago Clinicaltrials.gov Show details

AzurRx BioPharma, Inc. ClinicalTrials.gov Identifier: NCT04858425 Other Study ID Numbers: AZ-NICL-COV-1 : First Posted: April 26, 2021 Key Record Dates: Last Update Posted: October 8, 2021 Last Verified: October 2021 Individual Participant Data …

Category: Contact NumberShow more

AzurRx BioPharma: an undervalued company Richmond Club

4 hours ago Richmondclub.com Show details

AzurRx BioPharma has developed a synthetic alternative that reduces that number to eight to 16 pills a day. Courtesy of AzurRx BioPharma, Inc. Approximately 130,000 people in the United States have trouble digesting the food that they eat due to a condition called Exocrine Pancreatic Insufficiency (EPI), which affects 30,000 people living with

Category: Contact NumberShow more

First Wave Bio Crunchbase

4 hours ago Crunchbase.com Show details

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD). The solutions include a gut-restricted small molecule that can be formulated for either oral or rectal administration to treat ulcerative colitis among other IBDs, giving UC patients more accessible and cost-effective

Category: Contact NumberShow more

AzurRx BioPharma to Change Corporate Name to First Wave

1 hours ago Forextv.com Show details

(502) 589-7020

Suite 502. Boca Raton, Florida 33431. Phone: (502) 589-7020. [email protected] Media contact: Tiberend Strategic Advisors, Inc. Johanna Bennett / David Schemelia / Ingrid Mezo. (212) 375-2665

Category: Contact NumberShow more

AzurRx BioPharma BIO International Convention BIO

4 hours ago Bio.org Show details

AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company has a pipeline of three gut-restricted GI assets. The lead therapeutic candidate is MS1819, a recombinant lipase for the treatment of exocrine

Category: Contact NumberShow more

AZURRX BIOPHARMA, INC. MarketScreener.com

1 hours ago Marketscreener.com Show details

AzurRx BioPharma, Inc. is a clinical development-stage biopharmaceutical company. The Company is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The Company's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101.

Category: Contact NumberShow more

Azurrx Biopharma, Inc. (AZRX) 10K Annual Reports Last10K

6 hours ago Last10k.com Show details

Azurrx Biopharma, Inc. (AZRX) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020. Home SEC Filings Azurrx Biopharma, Inc. (AZRX) 10-K Annual Report Wed Mar 31 2021. 10-K Annual Report Summary. 10-K Annual Report. 10-K YoY Changes.

Category: Contact NumberShow more

AzurRx BioPharma Announces Reverse Stock Split Benzinga

1 hours ago Benzinga.com Show details

(561) 589-7020

777 Yamato Road, Suite 502. Boca Raton, FL 33431. Phone: (561) 589-7020. [email protected]azurrx.com. Media contact: Tiberend Strategic Advisors, Inc. Johanna Bennett/Ingrid Mezo. (212) 375-2665/ (646) 604

Category: Contact NumberShow more

Best Biopharma Industry Stocks To Invest In Today YouTube

3 hours ago Youtube.com Show details

For more information about AzurRx, click here: https://richmondclub.com/azurrx-biopharma-inc/Learn more about one of our Best Biopharma Industry Stocks To In

Category: Contact NumberShow more

AzurRx BioPharma Inc AZRX U.S. News & World Report

7 hours ago Money.usnews.com Show details

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. 12 Number of Employees Contact U.S

Category: Contact NumberShow more

AzurRx BioPharma Announces Positive Topline Data For Phase

3 hours ago Globenewswire.com Show details

AzurRx BioPharma, Inc. ( NASDAQ: AZRX) is a clinical stage biopharmaceutical company specializing in the development of targeted, non …

Category: Contact NumberShow more

AzurRx BioPharma to Change Corporate Name to First Wave

3 hours ago Stocktitan.net Show details

Formerly known as AzurRx BioPharma, Inc., the Company previously announced that it would rename itself First Wave BioPharma, Inc. and change its ticker symbol to "FWBI" in connection with its acquisition of First Wave Bio, Inc. in a stock and …

Category: Contact NumberShow more

AzurRx BioPharma to Change Corporate Name to First Wave

1 hours ago Firstwavebio.com Show details

Company to begin trading on Nasdaq under new ticker symbol, “FWBI”, effective September 22. BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, …

Category: Contact NumberShow more

AzurRx BioPharma Announces Positive Topline Data For Phase

7 hours ago Stocktitan.net Show details

(561) 589-7020

AzurRx BioPharma, Inc. 777 Yamato Road, Suite 502 Boca Raton, FL 33431 Phone: (561) 589-7020 [email protected]azurrx.com. Media contact: Tiberend Strategic Advisors, Inc. Johanna Bennett / David Schemelia (212) 375-2665 / (609) 468-9325 [email protected] / …

Category: Contact NumberShow more

Azurrx Stock Today Macroaxis

3 hours ago Macroaxis.com Show details

Azurrx Biopharma is trading at 3.75 as of the 20th of September 2021; that is -2.34 percent decrease since the beginning of the trading day. The stock's open price was 3.84. Get the latest Azurrx Biopharma detailed stock quotes, stock trade data, stock price info, and performance analysis, including Azurrx Stock investment advice, charts, stats and more.

Category: Contact NumberShow more

AzurRx BioPharma : Announces Reverse Stock Split

8 hours ago Marketscreener.com Show details

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it intends to effect a reverse stock split of its …

Category: Contact NumberShow more

AzurRx BioPharma Announces Positive Interim Data Yahoo

9 hours ago Finance.yahoo.com Show details

AzurRx BioPharma Announces Positive Interim Data From First Patient Cohort in Phase 2 Clinical Trial of MS1819 in Combination with PERT Therapy in the Treatment of

Category: Contact NumberShow more

AzurRx BioPharma Inc. Analyst Estimates MarketWatch

5 hours ago Marketwatch.com Show details

AzurRx BioPharma Inc. analyst estimates, including AZRX earnings per share estimates and analyst recommendations.

Category: Contact NumberShow more

Is AzurRx BioPharma Inc (AZRX) a Good Buy in the

1 hours ago Investorsobserver.com Show details

AzurRx BioPharma Inc is near the middle in its industry group according to InvestorsObserver.AZRX gets an overall rating of 39. That means it scores higher than 39 percent of stocks. AzurRx BioPharma Inc gets a 59 rank in the Biotechnology industry. Biotechnology is number 100 out of 148 industries.

Category: Contact NumberShow more

AzurRx BioPharma Announces Reverse Stock Split – The

1 hours ago Thewealthiestinvestor.com Show details

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it intends to effect a reverse stock split of its …

Category: Contact NumberShow more

AzurRx Acquires First Wave Bio Invesbrain

4 hours ago Invesbrain.com Show details

Florida-based AzurRx BioPharma is bolstering its gastrointestinal disease pipeline with the $229 million acquisition of First Wave Bio and its small molecule therapeutics for auto-immune inflammatory bowel diseases (IBD) and other serious conditions this morning. The move positions the company to carve out a significant slice of the IBD market share.

1. Author: Andrew Humphreys

Category: Contact NumberShow more

AzurRx BioPharma Submits an Investigational New Drug

4 hours ago Nz.finance.yahoo.com Show details

Proposed Phase 1b/2a clinical trial designed to determine safety and potential efficacy of oral and topical FW-420BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) …

1. Author: Azurrx Biopharma, Inc.

Category: Contact NumberShow more

AzurRx BioPharma Stock Analysis 2021 AZRX Macroaxis

2 hours ago Macroaxis.com Show details

The current price rise of AzurRx BioPharma could raise concerns from investors as the firm it trading at a share price of 3.45 on 625,709 in volume. The company directors and management may have good odds in positioning the firm resources to exploit market volatility in November.The stock standard deviation of daily returns for 90 days investing horizon is currently 92.56.

Category: Contact NumberShow more

Breaking News: AZRX latest news. The Fly

9 hours ago Thefly.com Show details

AZRX AzurRx BioPharma $3.54 / +0.17 (+5.04%). 09/14/21 AzurRx BioPharma CEO issues letter to shareholders on name change, acquisition 09/13/21 AzurRx BioPharma acquires First Wave Bio in cash, stock deal valued at $229M

Category: Contact NumberShow more

AzurRx BioPharma, Inc.: AzurRx BioPharma Announces Reverse

7 hours ago Finanznachrichten.de Show details

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), ("AzurRx" or the "Company"), a clinical stage biopharmaceutical company specializing in the development

Rating: 3/5(1)
Price: €2.33

Category: Contact NumberShow more

AZRX Stock Azurrx Biopharma, Inc. SEC Filings Donuts

Just Now Sec.report Show details

AzurRx BioPharma, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by AzurRx BioPharma, Inc..

Category: Contact NumberShow more

AzurRx BioPharma, Inc. hiring CMC Manager in LinkedIn

1 hours ago Linkedin.com Show details

6 days agoBe among the first 25 applicants. See who AzurRx BioPharma, Inc. has hired for this role. Report this job. The CMC Manager will own CDMO relationship, deliverables and budgets for

Category: Contact NumberShow more

First Wave BioPharma Launched: AzurRx BioPharma And First

7 hours ago Pressrelease.cc Show details

AzurRx BioPharma, Inc.’s (NASDAQ: FWBI) value-proposition was excellent before. But, after its $229 million acquisition of First Wave Bio, Inc. in a stock and cash transaction, it got even better.

Category: Contact NumberShow more

Will Current Price Volatility Hamper AzurRx BioPharma Inc

1 hours ago Marketingsentinel.com Show details

AzurRx BioPharma Inc. (NASDAQ:AZRX)’s Major holders. Insiders own 0.82% of the company shares, while shares held by institutions stand at 6.21% with a share float percentage of 6.26%. Investors are also buoyed by the number of investors in a company, with AzurRx BioPharma Inc. having a total of 31 institutions that hold shares in the company.

Category: Contact NumberShow more

AzurRx BioPharma announces reverse stocksplit Latest

4 hours ago Filingsearch.com Show details

AzurRx BioPharma, Inc. (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares.

Category: Contact NumberShow more

AzurRx BioPharma Announces Positive GlobeNewswire

2 hours ago Globenewswire.com Show details

AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a biopharmaceutical company specialized in the research and development of non-systemic biologics …

Category: Contact NumberShow more

AzurRx BioPharma Announces Positive Topline Data For Phase

3 hours ago Benzinga.com Show details

BOCA RATON, Fla., Aug. 18, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ:AZRX), a company specializing in the development of targeted, non-systemic therapies

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes